Jon Jones became the UFC Light Heavyweight Champion for a second time at UFC 232, defeating Alexander Gustafsson by third round TKO in the main event encounter.
The whole event was shifted from Las Vegas, Nevada to Inglewood, California by the UFC after the Nevada State Athletic Commission (NSAC) found an abnormality in Jones’ drug test.
One stipulation applied by the California State Athletic Commission (CSAC) that Jones had to follow when the show was moved was to undergo additional testing by the Voluntary Anti-Doping Agency (VADA), while still undergoing testing from the United States Anti-Doping Agency (USADA).
According to a report from MMA Junkie, VADA testing for Jones will continue after UFC 232 and could go on for another three to six months. This will coincide with random drug tests from USADA, which will continue as long as Jones is under a UFC contract. Jones has passed all drug tests since the failed drug test in line with UFC 214, something the fighter took to social media to celebrate.
Jones is still seeking a license from the NSAC to compete this coming March at UFC 235, as the champion is expected to defend the gold against the #3 ranked Anthony Smith in the main event of the show.